Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy.

Alderson KL, Zhou Q, Berner V, Wilkins DE, Weiss JM, Blazar BR, Welniak LA, Wiltrout RH, Redelman D, Murphy WJ.

J Immunol. 2008 Mar 1;180(5):2981-8.

2.

Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.

Yi T, Li X, Yao S, Wang L, Chen Y, Zhao D, Johnston HF, Young JS, Liu H, Todorov I, Forman SJ, Chen L, Zeng D.

J Immunol. 2011 Mar 1;186(5):2739-49. doi: 10.4049/jimmunol.1002939. Epub 2011 Jan 24.

3.

Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.

Phares TW, Ramakrishna C, Parra GI, Epstein A, Chen L, Atkinson R, Stohlman SA, Bergmann CC.

J Immunol. 2009 May 1;182(9):5430-8. doi: 10.4049/jimmunol.0803557.

4.

Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance.

Fukaya T, Takagi H, Sato Y, Sato K, Eizumi K, Taya H, Shin T, Chen L, Dong C, Azuma M, Yagita H, Malissen B, Sato K.

Blood. 2010 Sep 30;116(13):2266-76. doi: 10.1182/blood-2009-10-250472. Epub 2010 Jun 23.

5.

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N.

J Immunol. 2005 Jun 1;174(11):6648-56.

6.

Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.

Ritprajak P, Hashiguchi M, Tsushima F, Chalermsarp N, Azuma M.

J Immunol. 2010 May 1;184(9):4918-25. doi: 10.4049/jimmunol.0902478. Epub 2010 Apr 2.

7.

B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.

Lin PY, Sun L, Thibodeaux SR, Ludwig SM, Vadlamudi RK, Hurez VJ, Bahar R, Kious MJ, Livi CB, Wall SR, Chen L, Zhang B, Shin T, Curiel TJ.

J Immunol. 2010 Sep 1;185(5):2747-53. doi: 10.4049/jimmunol.1000496. Epub 2010 Aug 4.

8.

Expression of programmed death 1 ligands by murine T cells and APC.

Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H.

J Immunol. 2002 Nov 15;169(10):5538-45.

9.

Expression of B7-H1 in inflammatory renal tubular epithelial cells.

Chen Y, Zhang J, Li J, Zou L, Zhao T, Tang Y, Wu Y.

Nephron Exp Nephrol. 2006;102(3-4):e81-92. Epub 2005 Nov 11.

PMID:
16282703
10.

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.

Yamazaki T, Akiba H, Koyanagi A, Azuma M, Yagita H, Okumura K.

J Immunol. 2005 Aug 1;175(3):1586-92.

11.

B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals.

Mirza N, Duque MA, Dominguez AL, Schrum AG, Dong H, Lustgarten J.

J Immunol. 2010 May 15;184(10):5466-5474. doi: 10.4049/jimmunol.0903561. Epub 2010 Apr 7.

12.

Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.

Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K, Machida U, Iwai H, Azuma M, Chen L, Watanabe M.

J Immunol. 2003 Oct 15;171(8):4156-63.

13.

FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.

Ghebeh H, Barhoush E, Tulbah A, Elkum N, Al-Tweigeri T, Dermime S.

BMC Cancer. 2008 Feb 23;8:57. doi: 10.1186/1471-2407-8-57.

14.

Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.

Won TJ, Jung YJ, Kwon SJ, Lee YJ, Lee DI, Min H, Park ES, Joo SS, Hwang KW.

Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3. Epub 2010 Nov 30.

PMID:
21116786
15.

Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.

Currie AJ, Prosser A, McDonnell A, Cleaver AL, Robinson BW, Freeman GJ, van der Most RG.

J Immunol. 2009 Dec 15;183(12):7898-908. doi: 10.4049/jimmunol.0901060.

16.

Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.

Okudaira K, Hokari R, Tsuzuki Y, Okada Y, Komoto S, Watanabe C, Kurihara C, Kawaguchi A, Nagao S, Azuma M, Yagita H, Miura S.

Int J Oncol. 2009 Oct;35(4):741-9.

PMID:
19724910
17.

PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.

Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, Eyrich M.

Transplantation. 2007 Jul 27;84(2):214-22. Erratum in: Transplantation. 2008 Mar 27;85(6):910. Perikles, Simon [corrected to Simon, Perikles].

PMID:
17667813
18.

Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

Wei S, Shreiner AB, Takeshita N, Chen L, Zou W, Chang AE.

Cancer Res. 2008 Jul 1;68(13):5432-8. doi: 10.1158/0008-5472.CAN-07-6598.

19.

B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells.

Ding Q, Lu L, Wang B, Zhou Y, Jiang Y, Zhou X, Xin L, Jiao Z, Chou KY.

J Immunol. 2006 Sep 15;177(6):3606-14.

20.

B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance.

Waisman A, Yogev N.

Eur J Immunol. 2009 Jun;39(6):1448-51. doi: 10.1002/eji.200939541.

Supplemental Content

Support Center